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We  developed  a novel  PCR-based  pre-ampliﬁcation  (PreAmp)  technology  that  can  increase  the  abun-
dance  of over  350 target  genes  one  million-fold.  To  assess  potential  bias  introduced  by  PreAmp  we  utilized
ERCC  RNA  reference  standards,  a model  system  that  quantiﬁes  measurement  error  in  RNA  analysis.  We
assessed  three  types  of  bias:  ampliﬁcation  bias,  dynamic  range  bias  and  fold-change  bias.  We  show  that
our PreAmp  workﬂow  introduces  only  minimal  ampliﬁcation  and  fold-change  bias  under  stringent  condi-
tions. We  do  detect  dynamic  range  bias  if a  target  gene  is  highly  abundant  and  PreAmp  occurred  for  16 or
more PCR  cycles;  however,  this  type of  bias  is easily  correctable.  To assess  PreAmp  bias in a gene  expres-
sion  proﬁling  experiment,  we  analyzed  a  panel  of genes  that are  regulated  during  differentiation  using
the  NTera2  stem  cell  model  system.  We  ﬁnd  that results  generated  using  PreAmp  are  similar  to  resultsene expression proﬁling
ias
CR
RCC
obtained  using  standard  qPCR  (without  the  pre-ampliﬁcation  step).  Importantly,  PreAmp maintains  pat-
terns of gene  expression  changes  across  samples;  the  same  biological  insights  would  be derived from
a  PreAmp  experiment  as  with  a standard  gene  expression  proﬁling  experiment.  We  conclude  that  our
PreAmp  technology  can facilitate  analysis  of  extremely  limited  samples  in  gene  expression  quantiﬁcation
experiments.
© 2015  The  Authors.  Published  by  Elsevier  GmbH.  This  is an  open  access  article  under  the CC. Introduction
Pre-ampliﬁcation (PreAmp) of nucleic acid is a powerful tech-
ique that allows for the analysis of large numbers of target genes
rom limiting samples. PreAmp can be achieved through whole
ranscriptome ampliﬁcation [1] or at the level of targeted gene
anels using PCR-based methodology [2,3]. However, there is a
egitimate concern that PreAmp might change a sample to an extent
hat results generated from it are misleading or inaccurate. Better
nderstanding of the limitations of a PreAmp-based workﬂow is
ecessary to ensure the reliability of research results.
To address such concerns, the National Institute of Standardsnd Technology (NIST), in conjunction with the External RNA con-
rols consortium (ERCC) developed a set of reference standards to
valuate the performance of RNA quantiﬁcation systems and work-
Abbreviations: PreAmp, pre-ampliﬁcation; ERCC, external RNA controls con-
ortium; NIST, National Institute of Standards and Technology; NT2, NTera2; RA,
etinoic acid.
∗ Corresponding author.
E-mail addresses: steven okino@bio-rad.com (S.T. Okino),
ichelle kong@bio-rad.com (M.  Kong), haya sarras@bio-rad.com (H. Sarras),
an wang@bio-rad.com (Y. Wang).
ttp://dx.doi.org/10.1016/j.bdq.2015.12.001
214-7535/© 2015 The Authors. Published by Elsevier GmbH. This is an open access artic
.0/).BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
ﬂows [4,5]. The ERCC standards are mixtures of up to 96 synthetic
RNAs that are spiked into an RNA sample and processed and quanti-
ﬁed along with the natural RNAs. The amount of each ERCC RNA in a
mixture is precisely deﬁned; the performance of an RNA quantiﬁca-
tion workﬂow/platform is determined by comparing the measured
amount with the actual, deﬁned amount of each ERCC control RNA.
In addition, by spiking two  sets of ERCC standards (with deﬁned
ratios of each ERCC target) into two different biological samples,
the accuracy in quantifying gene expression differences between
samples can be determined. ERCC standards have been used to
assess qPCR, digital PCR, microﬂuidic qPCR, microarray and RNA-
seq platforms for their precision, accuracy and detection limits in
RNA quantiﬁcation [6–10].
There are two  fundamental challenges in PreAmp reactions
because multiple targets are ampliﬁed simultaneously. The ﬁrst
challenge is increasing the capacity of the ampliﬁcation reaction
to allow targets of vastly different starting quantity to be efﬁ-
ciently ampliﬁed through every PCR cycle. The second challenge
is maintaining target ampliﬁcation speciﬁcity in the presence of
large numbers of primers. Unless both challenges are addressed in a
PreAmp reagent, the probability of having biased pre-ampliﬁcation
will be high. We  developed a PreAmp reagent that utilizes an engi-
neered DNA polymerase with improved binding afﬁnity to DNA
le under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
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Fig. 1. Fold-change bias of ERCC standards. ExFold spike in-mixtures were added to 10 ng NT2 RNA, reverse transcribed and pre-ampliﬁed for 14 PCR cycles. ERCC targets
were  quantiﬁed by qPCR using three technical replicates, the experiment was performed one time. Fold-change measurements for each ERCC target are plotted against target
abundance. Results show the measured difference, between samples, of the amount of each ERCC target (colored circles) and the actual difference that should be detected
(Fig. 1A–C; colored lines at 1.0, 0.585, 0 and −2.0 Cq units representing RNA abundance ratios of 2–1, 1.5–1, 1–1 and 1–4 respectively). (A) Analysis of samples that were not
pre-ampliﬁed. (B) Analysis of samples in which 88 ERCC targets were pre-ampliﬁed. (C) Analysis of samples in which 355 targets were pre-ampliﬁed. (D) Overall fold-change
bias  for 88 ERCC targets. No PreAmp samples (red circles), 88-plex PreAmp samples (yellow circles), 355-plex PreAmp samples (blue circles).
S.T. Okino et al. / Biomolecular Detection and Quantiﬁcation 6 (2016) 13–21 15
Fig. 2. Fold-change bias of native target genes with limited sample. cDNA derived from NT2 cells treated with RA for 0–7 days were pre-ampliﬁed for 10 PCR cycles and used
to  quantify native target genes by qPCR; 100 pg, 1 ng and 10 ng cDNA was used in the PreAmp reactions. 1 g cDNA that was not pre-ampliﬁed was also used to quantify target
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ith  TBP and assuming that there are 10 TBP copies per cell. The experiment was pe
rror  bars represent standard deviation. Data for selected target genes that show R
nd, consequently, dramatically increased processivity. This results
n improved PreAmp reaction capacity which ensures that all tar-
ets are efﬁciently ampliﬁed [11]. We  also focused our PreAmp
eagent formulation efforts to mediate extremely stringent speci-
city of primer annealing.
To provide a stringent assessment of our new PreAmp reagent,
e used the ERCC controls to quantify bias in a gene expression pro-
ling experiment involving stem cell differentiation. We  then used
he ERCC information to discriminate regulated genes from back-
round noise. Our ﬁndings, from analysis of ERCC standards and
atural target genes, demonstrate that our novel PreAmp reagent
ill provide accurate results in gene expression proﬁling experi-
ents.
. Materials and methods
.1. Cell culture and sample processing
NTera2 cells (NT2) were obtained from the American Type Cul-
ure Collection (Manassas, VA) and cultured as directed. To induce
ifferentiation, cells were treated with 10 M all-trans-Retinoic
cid (Cat# R2625, Sigma–Aldrich, St. Louis MO)  for 0, 1, 2, 3, 4
r 7 days. RNA was isolated using the Aurum Total RNA Mini Kit
hich incorporates an on-column genomic DNA clearance step
Cat# 7326820, Bio-Rad Laboratories, Hercules, CA), quantiﬁed
ith a NanoDrop ND-1000 spectrophotometer (Thermo Fischer
cientiﬁc, Waltham, MA)  and stored at −80 ◦C. ERCC ExFold RNA
pike-in Mixes (Cat# 4456739, Thermo Fischer Scientiﬁc, Waltham,
A)  were diluted and spiked into RNA samples which were then
everse transcribed using iScript Reverse Transcription Supermix
s directed by the manufacturer (Cat# 1708849, Bio-Rad Laborato-
ies, Hercules, CA) to make stock cDNA samples which were storedet gene was determined and expressed as “RNA copies per cell” after normalizing
ed three times, each with two technical replicates, the average values are reported.
ced changes are shown.
at −20 ◦C. Stock cDNA samples were pre-ampliﬁed for 10–20 cycles
using SsoAdvanced PreAmp Supermix as directed by the manufac-
turer (Cat# 1725160, Bio-Rad Laboratories, Hercules, CA) diluted
at least 5-fold and stored at −20 ◦C. PreAmp was performed with
panels of assays which include PrimePCR PreAmp assays (Bio-Rad
Laboratories, Hercules, CA), assays culled from public databases,
assays designed using online software tools and assays from pub-
lished manuscripts (Supplemental Fig. 1); primers were at a ﬁnal
concentration of 50 nM each. Target genes were quantiﬁed by qPCR
using SsoAdvanced Universal SYBR Green Supermix (Cat# 1725270,
Bio-Rad Laboratories, Hercules, CA) and CFX96 or CFX384 Real-
Time PCR Detection Systems (Bio-Rad Laboratories, Hercules, CA)
using 20 l or 10 l reaction volumes respectively. Genomic DNA
contamination was  assessed using the PrimePCR DNA Contamina-
tion Control (Cat# 10025352, Bio-Rad Laboratories, Hercules, CA).
As a no-PreAmp control, stock cDNA was used to quantify gene tar-
gets directly by standard qPCR using SsoAdvanced Universal SYBR
Green Supermix. qPCR conditions were: 98 ◦C for 2 min; 40 cycles
of (98 ◦C, 5 s; 60 ◦C, 30 s); melt curve analysis, 65–98 ◦C, 0.5 ◦C incre-
ments, 5 s hold. CFX Manager version 3.1 was used for qPCR analysis
(Bio-Rad Laboratories, Hercules, CA). A synthetic DNA interplate
calibrator was used to set the Cq baseline.
2.2. Measurement of fold-change bias
The two ERCC ExFold RNA Spike-in mixes contain in-vitro tran-
scribed RNA transcripts in 4 sub-pools that have set ratios between
the mixes (1:1, 1:1.5, 1:2 and 4:1). To quantify fold-change bias,
ExFold mixes were spiked into RNA samples and processed as
described above; the amount of each ERCC target in each sample
was then determined by qPCR. The 1:1 sub-pool was  used as a cal-
ibrator to normalize the Mix  1 and Mix  2 results. To visualize bias
16 S.T. Okino et al. / Biomolecular Detection and Quantiﬁcation 6 (2016) 13–21
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ange  were quantiﬁed by qPCR using three technical replicates, the experiment w
ene  abundance (Cq).
he Cq value between the Mix  1 and Mix  2 samples was  deter-
ined for each target and plotted against the average no PreAmp Cq
alue. Fold-change bias was calculated as the difference between
he observed Cq and the theoretical Cq for each ERCC target. The
heoretical Cq is 0, 0.585, 1.0 and 2.0 for the 1:1, 1:1.5, 1:2 and
:1 sub-pools, respectively. Variation in fold-change measurement
rror was calculated using the equivalence test from JMP  statisti-
al software version 12.1.0 (SAS, Cary, NC), the practical difference
hreshold was speciﬁed as the standard deviation of the no PreAmp
old change measurement error.
.3. Limits-of-detection of fold-change measurement
Fold-change bias 95% conﬁdence intervals were determined
sing Microsoft Excel 2010 for the Cq values illustrated in
ig. 1B and rounded-up to the closest 0.5Cq. We  analyzed three
ifferent ranges of target abundance, average no PreAmp Cq value
ess than 30, between 30 and 32.5, and greater than 32.5. The limit
f detection was estimated as 2-fold the 95% conﬁdence interval.
or example, if the fold-change 95% conﬁdence interval for targets
etween 30 and 32.5 was calculated as 1.0Cq, then 2-fold this value
s 2.0Cq, which represents a 4-fold change. Therefore, targets with
 no PreAmp Cq value between 30 and 32.5 have a 4-fold change
imit of detection.-ampliﬁed for 12 PCR cycles; natural target genes encompassing a wide expression
formed one time. Results show the relationship between sample input and target
2.4. Measurement of ampliﬁcation bias
Analysis of the stock cDNA samples by PreAmp and by stan-
dard qPCR was  performed three times independently. PreAmp
ampliﬁcation bias was calculated as “Ampliﬁcation bias = (Cq Tar-
get (no-PreAmp) − Cq Target (PreAmp)) − 7.03” where 7.03 is a constant
derived from 14 PreAmp cycles and 5-fold sample dilution, which
reﬂects the theoretical Cq between the no-PreAmp and PreAmp
target gene Cq values if PreAmp is 100% efﬁcient; a PreAmp bias
score of 0 indicates that target gene PreAmp is 100% efﬁcient.
3. Results
3.1. Analysis of fold-change bias using ERCC controls
To assess bias introduced by PreAmp we used the ERCC ExFold
RNA spike-in control product; this product consists of two tubes
that contain the same ERCC RNAs at precisely deﬁned amounts
and ratios. Analysis of the ERCC standards spiked into two differ-
ent biological samples reveals the ability of a workﬂow to quantify
differences between samples [10]. We  added the ExFold mixtures
to two  RNA samples and converted them to cDNA. We then pre-
ampliﬁed the cDNA samples for 14 cycles using PreAmp primer
panels targeting either 88 ERCC RNAs only (88-plex PreAmp) or the
S.T. Okino et al. / Biomolecular Detection and Quantiﬁcation 6 (2016) 13–21 17
Fig. 4. Dynamic range bias. ExFold spike in-mixtures were added to 10 ng NT2 RNA, reverse transcribed and pre-ampliﬁed for 10–20 PCR cycles; ERCC targets were quantiﬁed
by  qPCR using two technical replicates, the experiment was performed one time. (A) The measured amount of ERCC target gene is plotted as a function of actual RNA abundance.
All  ERCC targets can be detected in the no PreAmp sample and in the samples processed for 14 PreAmp cycles. For samples processed for 20 PreAmp cycles, quantiﬁcation
of  targets in the 1 million copy range, have a Cq value less than 5 and are of unreliable value. (B) qPCR results for ERCC-00144, which contained 5,513 copies in the PreAmp
reaction, show good results over the entire ampliﬁcation range. (C) qPCR results for ERCC-00074, which contained 2,822,879 copies in the PreAmp reaction, show poor results
when ampliﬁed for 18 or 20 PCR cycles.
18 S.T. Okino et al. / Biomolecular Detection and Quantiﬁcation 6 (2016) 13–21
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55  targets were quantiﬁed by qPCR using two technical replicates, the experimen
ene  expression.
RCC RNAs plus an additional 267 target genes (355-plex PreAmp,
ee Supplemental Table 1 for gene targets and assay information).
e  then quantiﬁed each ERCC transcript in the PreAmp’d samples
s well as in the original, non-ampliﬁed cDNA samples.
Our results show the measured difference versus the actual pre-
eﬁned difference of each ERCC RNA spiked into the two samples
Fig. 1A–C). We  ﬁnd that fold-change measurement bias appears
imilar when comparing the no PreAmp, 88-plex PreAmp and
55-plex PreAmp results. In Fig. 1D we show the measurement
rror in fold-change results; no measurement error would have
 Cq value of 0, a Cq value of 1 indicates a measurement
rror of 100%. We  observe that measurement error increases as
he amount of ERCC target RNA decreases. This ﬁnding is expected
nd is consistent with stochastic partitioning of a small number
f RNA molecules in the qPCR reactions. We  then quantiﬁed the
old-change measurement error associated with RNA abundance
anges (Table 1). We  ﬁnd that for RNAs with moderate to high
bundance (Cq < 30) fold-change measurement error is, on average,
nly about 0.1Cq representing 7% error. For low abundance RNAs
Cq between 30 and 32.5) measurement error averages 20%, for
race RNAs (Cq > 32.5) 75% average measurement error is observed.
mportantly, a test of statistical equivalence indicates that PreAmp
88-plex or 355-plex) has only a slight effect on fold-change mea-
urement error relative to the no PreAmp samples (only the trace
NAs in the 88-plex PreAmp sample has a p-Value above the 0.05
hreshold that indicates a PreAmp bias, the p-value is 0.0515). These
ndings are consistent with a previous report [6] and demonstrates
hat our PreAmp workﬂow only has low fold-change bias when
nalyzing trace expression target genes.
Our results also imply that the ability to detect a meaningful
ifference in RNA expression between two samples by RT-qPCR is
 function of RNA abundance. Using the ERCC RNAs as an internal
ontrol we estimated that the limits-of-detection of fold-change
easurement is 2-fold for moderately or highly expressed RNA tar-
ets, 4-fold for RNAs with low expression, and, at best, 8-fold for
NAs with trace expression (Table 1).
.2. Analysis of fold-change bias using regulated genes
Our ERCC-based work demonstrates that even high multi-
lex PreAmp does not introduce appreciable bias to fold-change
easurements. However, the ERCC model system is based onpike-in of in-vitro transcribed RNAs, not natural RNA transcripts.
o determine if the PreAmp workﬂow can accurately quantify
ene expression changes of natural targets, we analyzed RNA
amples puriﬁed from NT2 cells, an established model system of transcribed and pre-ampliﬁed for 14 PCR cycles in a 355-plex PreAmp reaction. All
performed one time. Ampliﬁcation bias was determined and plotted against target
human stem cell behavior. When treated with retinoic acid (RA),
NT2 cells differentiate into neurons [12,13]; during differentia-
tion the expression of stem cell-speciﬁc biomarkers decrease while
the expression of neuron-speciﬁc biomarkers increase [14–17].
To identify genes regulated during differentiation we  applied the
fold-change limits-of-detection criteria established in the previ-
ous section (Table 1) to 267 genes involved in cell maintenance,
cell fate and adaptation. We  identiﬁed 34 regulated genes, which
include well known stem cell biomarkers such as NANOG and neu-
ral cell biomarkers such as NEUROD1 (Table 2). Most of these genes
were previously characterized to be involved in NT2 differentiation
[14–17], which is conﬁrmatory of our approach.
We analyzed a panel of 100 genes that are involved in lineage
determination (Supplemental Table 1). We  pre-ampliﬁed and ana-
lyzed varied amounts of cDNA (100 pg, 1 ng and 10 ng) derived
from NT2 cells treated with RA for 0, 1, 2, 3, 4 and 7 days; as a
no-PreAmp control, 1 g cDNA was used to quantify gene targets
directly by standard qPCR (10 ng/target, 1 g per 100 target panel).
We show data for several representative regulated target genes,
gene transcript levels are expressed as “RNA copies per cell” after
normalizing with TBP and assuming that there are 10 TBP copies
per cell [18]; this method of normalization provides information on
the relative level of target gene expression as well as fold-change
of RNA abundance (Fig. 2). Data presented in Supplemental Fig. 1
shows that TBP expression is relatively stable over the time course
of RA exposure changing less than 0.5Cq (25%), this justiﬁes its
use as a normalization gene. The assumption that there are 10 TBP
copies per cell does not affect fold-change results; it is used because
it provides a relative estimate of target gene levels in a biologically
relevant context.
We  ﬁnd that the gene expression proﬁling results obtained from
the PreAmp’d samples show similar trends as those derived from
the original cDNA samples, even though up to 10,000-fold less cDNA
is analyzed. This implies that PreAmp can analyze limited samples
effectively and that the same biological insights and conclusions
would be derived from an experiment using PreAmp and a standard
gene expression proﬁling experiment. Importantly, the changes in
gene expression observed over the NT2 differentiation time course
are consistent with previously published results [14–17] suggest-
ing that our results are accurate.
To further explore the dynamic range of sample input, we
pre-ampliﬁed varied amounts of cDNA, from 10 pg to 1 g, and
then used the samples to analyze gene targets that span a wide
expression range. Our results show a linear relationship between
sample input and target amount (Fig. 3). This demonstrates that
our PreAmp reagent has the capacity to analyze samples with a 6-
S.T. Okino et al. / Biomolecular Detection and Quantiﬁcation 6 (2016) 13–21 19
Table  1
Fold-change measurement error.
Target gene expression level (Cq)
<30 30–32.5 >32.5
No PreAmp Average fold change measurement error (Cq) 0.093 0.265 0.804
Average fold change measurement error (percent) 7% 20% 75%
88-plex PreAmp Average fold change measurement error (Cq) 0.094 0.162 0.578
Average fold change measurement error (percent) 7% 12% 49%
Statistical equivalence with no PreAmp. p-value (upper threshold) <0.0001a 0.0121a 0.0515
Statistical equivalence with no PreAmp. p-value (lower threshold) 0.0021a 0.0003a <0.0001a
355-plex PreAmp Average fold change measurement error (Cq) 0.108 0.119 0.380
Average fold change measurement error (percent) 8% 9% 30%
Statistical equivalence with no PreAmp. p-value (upper threshold) <0.0001a 0.0010a 0.0074a
Statistical equivalence with no PreAmp. p-value (lower threshold) 0.0205a 0.0050a 0.0002a
l
q
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GEstimated fold-change limits-of-detection 
a Statistically equivalent with no PreAmp.
og input range (10 pg to 1 g) and faithfully maintain the relative
uantity of gene targets over a wide expression level range (e.g. a
pan of 18Cq from POU5F1 to NEUROD1).
.3. Analysis of dynamic range bias
An important consideration in a PreAmp experiment is the num-
er of ampliﬁcation cycles. Typically, qPCR platforms require 10–14
reAmp cycles for single copy detection. However, microﬂuidic-
ased qPCR instruments have a nanoliter scale interrogation
olume and often require up to 20 PreAmp cycles to achieve sin-
le copy detection [19]. To assess bias associated with PreAmp
ycle number we used the ERCC controls which have wide range
f RNA abundance [10]. We  diluted the ExFold mixtures such that
ll targets should be present in a PreAmp reaction (2.5 copies
o 5.6 million copies). We  then pre-ampliﬁed the samples using
tandard (88-plex) and high multiplex (355-plex) conditions for
able 2
enes regulated by retinoic acid.
Target gene No PreAmp Avg Cq % Expression in RA treated cells
relative to control cells
T (Brachyury) 34.1 1%
OTX2 27.4 6%
DKK1 32.2 10%
NANOG 23.7 18%
DPPA3 29.7 22%
MIXL1 30.0 23%
TDGF1 24.6 23%
RARG 29.4 23%
PRDM14 26.3 24%
CD44 28.6 25%
PMAIP1 25.6 25%
POU5F1 21.0 26%
SOX9 27.6 27%
CA12 29.8 28%
THY1 24.5 47%
DLL3 28.8 307%
SNCG 26.8 404%
GABRB2 29.1 493%
CRABP2 20.0 831%
POU3F2 29.7 1280%
CDX1 30.1 1801%
MEIS1 28.6 1879%
RARB 28.6 1884%
HOXD4 29.3 3074%
ASCL1 28.6 3141%
HNF4A 31.5 3507%
LEFTY2 25.1 6656%
NEUROG2 33.2 8626%
FOXA1 33.3 9277%
HOXA4 33.5 10550%
PAX6 27.7 13467%
NEUROD1 35.2 13703%2-fold 4-fold 8-fold
10–20 PreAmp cycles; this reﬂects a target ampliﬁcation range of
103–106-fold. The amount of ERCC target detected, as a function
of RNA abundance, is shown in Fig. 4A. We ﬁnd that all ERCC tar-
gets can be detected in the no PreAmp sample and in the samples
processed for 14 PreAmp cycles. This implies that a moderate num-
ber of PreAmp cycles will not bias the 6-log dynamic range of target
detection. However, for samples that underwent 20 PreAmp cycles,
quantiﬁcation of targets in the 1 million copy range, corresponding
to a Cq value less than 5, are of unreliable value (see Fig. 4C).
To illustrate the dynamic range bias associated with a highly
expressed target we  show selected qPCR results. Fig. 4B shows
the qPCR traces for the moderate abundance target, ERCC-00144,
which is present at ∼5,500 copies in the PreAmp reaction. We  ﬁnd
that ampliﬁcation efﬁciency, with respect to cycle number, is linear
and close to 100%. However, for the high abundance target ERCC-
00074, which is present at over 2.8 million copies in the PreAmp
reaction, high numbers of PreAmp cycles results in poor target
quantiﬁcation, thus exhibiting dynamic range bias (Fig. 4C). We
conclude that high numbers of PreAmp cycles could bias results
for very highly expressed genes and, therefore, recommend using
the fewest number of PreAmp cycles required to achieve robust
single copy target gene detection. Supplementary Table 2 lists the
ampliﬁcation efﬁciency and dynamic range bias of all ERCC targets;
the results demonstrate that our PreAmp workﬂow supports quan-
titative target gene ampliﬁcation up to 1 million-fold under both
standard and high multiplex conditions.
The data presented in Fig. 4A was also analyzed quantitatively
to delineate salient properties of the PreAmp reaction (Table 3). We
ﬁnd that PreAmp ampliﬁes targets at all levels of abundance with
similar efﬁciency; this is reﬂected by a slope close to 1. We ﬁnd
that PreAmp decreases the Cq value associated with single copy
detection (X-intercept) by the expected 2 cycles for every 2 cycle
increase in PreAmp cycle number; this reﬂects linear ampliﬁca-
tion over 10–20 PreAmp cycles. We also observe a slight decrease
in the R2 values when using 18–20 PreAmp cycles, likely reﬂect-
ing unreliable qPCR quantiﬁcation of targets with extremely highly
abundance (see Fig. 4C).
3.4. Analysis of ampliﬁcation bias
Ampliﬁcation bias is the difference between the measured
amount of a target gene after pre-ampliﬁcation, relative to the the-
oretical amount. In practice, the theoretical target gene amount
can be estimated from the amount of target detected in the non-
ampliﬁed cDNA sample and the number of PreAmp cycles (see
Section 2). To assess ampliﬁcation bias, we compared target gene
levels in cDNA samples before and after 14 PreAmp cycles. For
each target gene we calculated the ampliﬁcation bias introduced
by PreAmp and plotted it against the level of target gene expres-
20 S.T. Okino et al. / Biomolecular Detection 
Table 3
Effect of PreAmp cycles on RNA detection.
PreAmp cycles ERCC mix  PreAmp plex Slope R2 X-int (Cq)
0 Mix  1 NA 1.005 0.983 37.3
0  Mix  2 NA 0.988 0.984 36.9
10  Mix  1 88 0.995 0.979 34.4
10  Mix  1 355 0.994 0.978 34.5
10  Mix  2 88 0.987 0.979 34.1
10  Mix  2 355 0.985 0.980 34.1
12  Mix  1 88 0.996 0.979 32.3
12  Mix  1 355 0.993 0.980 32.4
12  Mix  2 88 0.989 0.978 32.0
12  Mix  2 355 0.983 0.979 32.4
14  Mix  1 88 0.996 0.977 30.3
14  Mix  1 355 0.991 0.975 30.3
14  Mix  2 88 1.000 0.977 30.3
14  Mix  2 355 0.987 0.978 30.1
16  Mix  1 88 1.009 0.976 28.5
16  Mix  1 355 0.994 0.972 28.4
16  Mix  2 88 0.992 0.978 28.2
16  Mix  2 355 0.994 0.979 28.2
18  Mix  1 88 0.998 0.969 26.3
18  Mix  1 355 0.999 0.966 26.4
18  Mix  2 88 0.997 0.969 26.2
18  Mix  2 355 1.000 0.971 26.2
20  Mix  1 88 1.013 0.964 24.3
20  Mix  1 355 1.010 0.958 24.5
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p20  Mix  2 88 1.010 0.960 24.4
20  Mix  2 355 1.021 0.960 24.1
ion in the original sample (Fig. 5). We  considered gene targets
hat have a Cq ≥ 40 in the original sample to be not expressed and
xcluded them from analysis. We  observe that for 319 (91%) of the
46 expressed gene targets, PreAmp did not change the expression
evel by more than 1.0Cq.
. Discussion
We  developed a novel PreAmp reagent that features an
ngineered DNA polymerase designed to improve ampliﬁcation
apacity and efﬁciency. Here we report an in-depth analysis of the
ias our PreAmp reagent introduces into a gene expression pro-
ling experiment. We  analyzed three types of bias: ampliﬁcation
ias, dynamic range bias and fold-change bias.
Ampliﬁcation bias reﬂects PreAmp PCR efﬁciency and is a com-
only used parameter to measure PreAmp performance [1–3].
peciﬁcally, ampliﬁcation bias measures whether each target is
mpliﬁed at 100% efﬁciency throughout the PCR cycling. We ﬁnd
hat our PreAmp reagent performs well on this metric, even under
igh multiplex conditions (Fig. 5).
In a previous report the ampliﬁcation bias of 194 genes was
nalyzed using standard qPCR; 80% of targets were not altered by
ore than 1.0 Cq and about 91% of targets were not altered
y more than 1.5 Cq [2]. Our results show less ampliﬁcation
ias when analyzing 346 genes; 91% of targets were not altered by
ore than 1.0 Cq. This difference may  reﬂect differences in the
amples and/or target genes analyzed, it may  also reﬂect differences
n the reagents and overall workﬂow used in the analysis.
Interestingly however, even if a target gene exhibits ampli-
cation bias, as long as it is biased to the same extent in all
amples, relative gene expression results will still be accurate. Thus,
mpliﬁcation bias reproducibility is a key requirement for accu-
ate gene expression proﬁling results. Not surprisingly, given our
ene expression proﬁling data (Fig. 2), we ﬁnd that ampliﬁcation
ias standard deviation is extremely low, averaging 0.06Cq when
nalyzing technical replicates and averaging 0.17Cq when analyz-
ng multiple samples (Supplemental Fig. 2). These results reﬂect
he precision associated with our PreAmp-based gene expression
roﬁling analysis.and Quantiﬁcation 6 (2016) 13–21
Dynamic range bias measures the ability to accurately quan-
tify target genes over a wide range of abundance. Our standard, no
PreAmp gene expression proﬁling workﬂow can quantify the entire
6-log dynamic range of the ERCC controls. Pre-ampliﬁcation for up
to 14 PCR cycles can also accurately quantify the entire ERCC assay
set and, thus, does not introduce dynamic range bias. However, in
instances of high target gene expression coupled with a high num-
ber of PreAmp cycles (e.g. 20 cycles) target gene quantiﬁcation may
be compromised. Dynamic range bias was previously reported in
a microﬂuidic-based qPCR study and is quite consistent with our
ﬁndings [3]; a high number of PreAmp cycles biased the quantiﬁ-
cation of high abundance target genes. We  believe that dynamic
range bias will not be an issue in standard qPCR experiments. Such
bias is apparent in the qPCR traces (Fig. 4C), and can be alleviated
through sample dilution or use of fewer PreAmp cycles. For applica-
tions that require high levels of PreAmp, such as microﬂuidic-based
qPCR, our conclusions may  not apply. More work is necessary to
better quantify the various types of bias associated with high PCR
cycle PreAmp.
Fold-change measurement is fundamental to gene expression
proﬁling experiments; it allows for the comparison of target gene
expression levels across samples. To our knowledge, this is the
ﬁrst report that analyses fold-change bias using RNA reference
standards and natural target genes. Using the ERCC standards
we quantiﬁed fold-change measurement bias and found that our
PreAmp reagent does not introduce bias for target genes expressed
above trace levels (Cq < 32.5); for target genes that have trace
expression (Cq > 32.5) we do observe low bias and suggest that
only 8-fold and higher gene expression differences are detectable
(Table 1).
There are limitations to our PreAmp workﬂow; it has limited use
in detecting gene expression changes of less than 2-fold (Table 1).
To detect small changes a different platform, such as digital PCR, is
likely more appropriate [20].
We  also analyzed the expression of a panel of regulated target
genes across six samples; here we  found that the PreAmp results
are similar to the results using standard methodology (Fig. 2).
This ﬁnding is signiﬁcant and implies that PreAmp can be used
in gene expression proﬁling experiments without compromising
results. Indeed, we show that PreAmp faithfully maintains patterns
of relative gene expression changes (Fig. 2); the same insights and
conclusions would be drawn from a PreAmp-based experiment and
a standard gene expression proﬁling experiment.
Our novel PreAmp technology ampliﬁes over 350 gene targets
up to 1 million-fold. The high level of multiplex allows for the
incorporation of ERCC standards into a PreAmp-based workﬂow
as an internal control. We  ﬁnd that this control is valuable because
it both validates PreAmp performance and establishes screening
speciﬁcations to identify regulated genes with signiﬁcant expres-
sion changes (Tables 1 and 2). We  envision that such a workﬂow can
facilitate experimentation with very limited samples and lead to
advances in ﬁelds requiring sensitive and accurate gene expression
analysis, such as single cell biology.
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